Opioid Receptors in Heart Membranes Signal Through G-Proteins to Regulate Heart Cell Activity | Research

The takeaway

All three opioid receptor types (mu, delta, kappa) are present in cardiac membranes and signal through G-protein coupled pathways that inhibit adenylyl cyclase, revealing the heart's own opioid signaling system.

Complete cardiac opioid system
Mu, delta, and kappa opioid receptors all present and functional in purified heart cell membranes

What the researchers found

Mu, delta, and kappa opioid receptors in cardiac sarcolemma activate pertussis toxin-sensitive G proteins and inhibit adenylyl cyclase, confirming a complete opioid signaling pathway in the heart.

Why it matters

Confirming functional opioid receptors and their signaling pathways in the heart opens the door to understanding how opioid peptides protect cardiac tissue during stress and ischemia.

How the study worked

Highly purified canine cardiac sarcolemmal membranes were analyzed for opioid receptor binding, G protein activation (GTPase), and adenylyl cyclase inhibition using selective agonists for each receptor type.

What this study cannot tell us

In vitro study using isolated canine cardiac membranes. The functional consequences of this signaling in intact hearts were not assessed.

How to read the evidence

Moderate in vitro evidence with rigorous biochemical characterization in highly purified membrane preparations.

When this study was published

Published in 1996, this study provided key biochemical evidence for the cardiac opioid system that is now well-established.

The bigger picture

The cardiac opioid system is now recognized as important for cardioprotection during heart attacks. This study established the molecular machinery that makes this protection possible.

Questions still open

Could selective cardiac opioid receptor activation protect the heart during ischemia?
Do cardiac opioid receptor levels change with heart disease?

Common questions

Why does the heart have opioid receptors?

The heart's opioid receptors are part of a built-in protective system. When activated by endogenous opioid peptides during stress or ischemia, they trigger signaling pathways that help heart cells survive oxygen deprivation.

What is adenylyl cyclase inhibition?

Adenylyl cyclase is an enzyme that produces cAMP — a molecule that speeds up heart rate and increases contractile force. When opioid receptors inhibit this enzyme, they essentially calm the heart, reducing its oxygen demand during stress.

Read the original research

Opioid receptor agonists activate pertussis toxin-sensitive G proteins and inhibit adenylyl cyclase in canine cardiac sarcolemma.

Naunyn-Schmiedeberg's archives of pharmacology, 354(5), 643-9

View on PubMed ↗

Citation

Niroomand, F; Mura, R A; Piacentini, L; Kübler, W. (1996). Opioid receptor agonists activate pertussis toxin-sensitive G proteins and inhibit adenylyl cyclase in canine cardiac sarcolemma.. Naunyn-Schmiedeberg's archives of pharmacology, 354(5), 643-9.